Get the Stockscreener App
0.9299
1.07%
-0.0101
Pluri Inc stock is traded at $0.9299, with a volume of 9,118.
It is down -1.07% in the last 24 hours and down -18.43% over the past month.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
See More
Previous Close:
$0.94
Open:
$0.99
24h Volume:
9,118
Relative Volume:
0.76
Market Cap:
$11.73M
Revenue:
$1.08M
Net Income/Loss:
$-26.95M
P/E Ratio:
-0.3239
EPS:
-2.8712
Net Cash Flow:
$-21.69M
1W Performance:
-2.44%
1M Performance:
-18.43%
6M Performance:
-73.51%
1Y Performance:
-78.62%
1-Day Range:
$0.9299
$0.99
1-Week Range:
$0.8677
$0.99
52-Week Range:
$0.85
$4.865
Pluri Inc Stock (PLUR) Company Profile
Name
Pluri Inc
Sector
Industry
Phone
972-74-710-7171
Address
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Compare PLUR vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLUR
Pluri Inc
|
0.9299 | 11.73M | 1.08M | -26.95M | -21.69M | -2.8712 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Pluri Inc Stock (PLUR) Latest News
Plurilock Security Inc.: Quantum eMotion to Acquire Plurilock, Expanding Commercial Quantum and AI Cybersecurity Platform - FinanzNachrichten.de
Pluri Inc.Common Stock (Nasdaq:PLUR) Stock Quote - The Chronicle-Journal
Pluri (NASDAQ: PLUR) preps $200M shelf for future stock and warrant offerings - Stock Titan
Pluri: Fiscal Q4 Earnings Snapshot - WUSA9
Pluri Inc. FY 2026: Revenue $1.02M, EPS $(2.44) — 10-K Summary - TradingView
Pluri Inc. Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
Pluri Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Pluri Inc. (NASDAQ: PLUR) Share Price, PLUR Stock News, PLUR Share Price & Updates - Kalkine
Pluri Inc. (PLUR) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Pluri (PLUR) turns to private warrants for funding - Stock Titan
Insiders' US$14.6m Investments In Red Following Pluri's US$2.2m Dip In Market Value - simplywall.st
Pluri Inc. (NASDAQ: PLUR) Announces $1.50 Share Sale with 2.23M Pre-Funded Warrants in Direct Offering - kalkinemedia.com
Pluri Announces August 2026 Equity Financing Transaction - theglobeandmail.com
Pluri Inc. (PLUR) Edges Higher Above $1.46 Support as Consolidation ContinuesTick Index - dars.gov.et
Pluri Raises ~$3.0M in Registered Direct Offering With 5-Year Warrants; AGP Named Placement Agent - TradingView
Pluri Inc. (PLUR) Edges Higher Above $1.46 Support as Consolidation ContinuesMA Crossover - dars.gov.et
Pluri raises $3.3 million in registered direct offering By Investing.com - Investing.com South Africa
Pluri raises $3.3 million in registered direct offering By Investing.com - Investing.com UK
Pluri plans a $3.3 million share sale and rights to buy more shares - Stock Titan
Pluri raises $3.3 million in registered direct offering - Investing.com
Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor - The Manila Times
Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor - Yahoo Finance
Pluri (PLUR) director's 31,569-share grant vests over 3 years - Stock Titan
Pluri Inc. (PLUR) insider logs stock trades in new SEC filing - Stock Titan
Pluri (PLUR) Results at a Glance: The EPS Result Is Below Expectation; Trading Response: Shares Finish 0.57% UpQuarterly Earnings Report - vinanet.vn
Pluri (PLUR) Results at a Glance: The EPS Result Is Below Expectation; Trading Response: Shares Finish 0.57% UpEarnings Surprise Score - dars.gov.et
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment - Sahm
symbol__ Stock Quote Price and Forecast - CNN
Pluri Subsidiary to Acquire Fishway BV, Diluting Pluri Stake to 58% - Minichart
Pluri Subsidiary Acquires Fishway to Expand Cultivated Seafood - TipRanks
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment - marketscreener.com
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment - GlobeNewswire
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment - GlobeNewswire
Pluri Inc. (PLUR) Holds at $1.75 as Traders Eye Key Support and ResistanceBull Pennant - Vinanet
Pluri Inc. (PLUR) Holds at $1.75 as Traders Eye Key Support and ResistanceLast Point Support - dars.gov.et
PLUR Q2 2026 Earnings: Wider-Than-Expected Loss Reflects Continued Investment in Cell Therapy PipelineLong-Term Guidance - vinanet.vn
Pluri Inc. Revenue Breakdown – NASDAQ:PLUR - TradingView
Pluri Inc (PLUR) Stock News Today - TradingKey
Pluri Inc (PLUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PLUR Q2 2026 Earnings: Wider-than-Expected Loss Reflects Clinical-Stage InvestmentGross Profit Margin - vinanet.vn
PLUR Q2 2026 Earnings: Wider-than-Expected Loss Highlights Pre-Revenue Investment CostsManagement Guidance Update - vinanet.vn
Cellav Health and Aesthetics Ltd Completes Regulatory Registration of Regenativo+ in the UK - marketscreener.com
Pluri's subsidiary Cellav completes UK regulato... - Pluang
Pluri subsidiary completes UK regulatory registration for aesthetics product - Investing.com
Pluri’s Regenativo+ Is Registered for Sale in a $900M UK Market - Stock Titan
Pluri Inc (PLUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pluri Inc. (PLUR) Gains Slightly as Stock Tests Key Resistance Near $1.76GEX Level - dars.gov.et
Pluri Inc. (PLUR) Gains Slightly as Stock Tests Key Resistance Near $1.76Median Line - dars.gov.et
Pluri Inc. (PLUR) Gains Slightly as Stock Tests Key Resistance Near $1.76Strong Buy Stocks - dars.gov.et
Pluri Inc (PLUR) Balance Sheet - TradingKey
Pluri Inc Stock (PLUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):